메뉴 건너뛰기




Volumn 35, Issue 4, 2017, Pages 828-834

Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients

Author keywords

hemophagocytic lymphohistiocytosis; hemophagocytic syndrome; hemophagocytosis; immune activation; outcome of secondary hemophagocytic syndrome

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN; RITUXIMAB;

EID: 84973169237     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.2314     Document Type: Article
Times cited : (37)

References (24)
  • 1
    • 84929612515 scopus 로고    scopus 로고
    • Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders
    • Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev 2015; 26(3): 263–80.
    • (2015) Cytokine Growth Factor Rev , vol.26 , Issue.3 , pp. 263-280
    • Brisse, E.1    Wouters, C.H.2    Matthys, P.3
  • 2
    • 84877819974 scopus 로고    scopus 로고
    • Advances in understanding the pathogenesis of HLH
    • Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol 2013; 161(5): 609–622.
    • (2013) Br J Haematol , vol.161 , Issue.5 , pp. 609-622
    • Usmani, G.N.1    Woda, B.A.2    Newburger, P.E.3
  • 3
    • 84898663073 scopus 로고    scopus 로고
    • Hemophagocytic lymphohistiocytosis: pathogenesis and treatment
    • Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program 2013; 2013: 605–611.
    • (2013) Hematology Am Soc Hematol Educ Program , vol.2013 , pp. 605-611
    • Janka, G.E.1    Lehmberg, K.2
  • 4
    • 84907817138 scopus 로고    scopus 로고
    • Hereditary and acquired hemophagocytic lymphohistiocytosis
    • Zhang L, Zhou J, Sokol L. Hereditary and acquired hemophagocytic lymphohistiocytosis. Cancer Control 2014; 21(4): 301–312.
    • (2014) Cancer Control , vol.21 , Issue.4 , pp. 301-312
    • Zhang, L.1    Zhou, J.2    Sokol, L.3
  • 5
    • 84882782587 scopus 로고    scopus 로고
    • Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
    • Teachey DT, Rheingold SR, Maude SL, et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy. Blood 2013; 121(26): 5154–7.
    • (2013) Blood , vol.121 , Issue.26 , pp. 5154-5157
    • Teachey, D.T.1    Rheingold, S.R.2    Maude, S.L.3
  • 6
    • 78751681576 scopus 로고    scopus 로고
    • Successful treatment of severe paediatric rheumatic-disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
    • Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ. Successful treatment of severe paediatric rheumatic-disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford) 2011; 50(2): 417–9.
    • (2011) Rheumatology (Oxford) , vol.50 , Issue.2 , pp. 417-419
    • Miettunen, P.M.1    Narendran, A.2    Jayanthan, A.3    Behrens, E.M.4    Cron, R.Q.5
  • 7
    • 84894448683 scopus 로고    scopus 로고
    • Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability
    • Ho C, Yao X, Tian L, Li FY, Podoltsev N, Xu ML. Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am J Clin Pathol 2014; 141(1): 62–71.
    • (2014) Am J Clin Pathol , vol.141 , Issue.1 , pp. 62-71
    • Ho, C.1    Yao, X.2    Tian, L.3    Li, F.Y.4    Podoltsev, N.5    Xu, M.L.6
  • 8
    • 33845619137 scopus 로고    scopus 로고
    • HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
    • Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48(2): 124–131.
    • (2007) Pediatr Blood Cancer , vol.48 , Issue.2 , pp. 124-131
    • Henter, J.I.1    Horne, A.2    Aricó, M.3
  • 9
    • 80055079785 scopus 로고    scopus 로고
    • Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
    • Trottestam H, Horne A, Aricò M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 2011; 118(17): 4577–4584.
    • (2011) Blood , vol.118 , Issue.17 , pp. 4577-4584
    • Trottestam, H.1    Horne, A.2    Aricò, M.3
  • 10
    • 84923083822 scopus 로고    scopus 로고
    • Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis
    • Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 2015; 90(3): 220–224.
    • (2015) Am J Hematol , vol.90 , Issue.3 , pp. 220-224
    • Otrock, Z.K.1    Eby, C.S.2
  • 11
    • 84899943272 scopus 로고    scopus 로고
    • Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients
    • Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore) 2014; 93(2): 100–105.
    • (2014) Medicine (Baltimore) , vol.93 , Issue.2 , pp. 100-105
    • Li, J.1    Wang, Q.2    Zheng, W.3
  • 12
    • 84915731934 scopus 로고    scopus 로고
    • Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide
    • Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol 2015; 168(1): 63–68.
    • (2015) Br J Haematol , vol.168 , Issue.1 , pp. 63-68
    • Arca, M.1    Fardet, L.2    Galicier, L.3
  • 13
    • 84898886282 scopus 로고    scopus 로고
    • Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis
    • Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 2014; 89(4): 484–492.
    • (2014) Mayo Clin Proc , vol.89 , Issue.4 , pp. 484-492
    • Parikh, S.A.1    Kapoor, P.2    Letendre, L.3    Kumar, S.4    Wolanskyj, A.P.5
  • 14
    • 84955735455 scopus 로고    scopus 로고
    • Hemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years
    • Schram AM, Comstock P, Campo M, et al. Hemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years. Br J Haematol 2016; 172(3): 412–9.
    • (2016) Br J Haematol , vol.172 , Issue.3 , pp. 412-419
    • Schram, A.M.1    Comstock, P.2    Campo, M.3
  • 15
    • 84907408074 scopus 로고    scopus 로고
    • Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome
    • Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 2014; 66(9): 2613–2620.
    • (2014) Arthritis Rheumatol , vol.66 , Issue.9 , pp. 2613-2620
    • Fardet, L.1    Galicier, L.2    Lambotte, O.3
  • 16
    • 84960193018 scopus 로고    scopus 로고
    • 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
    • Ravelli A, Minoia F, Davì S, et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 2016; 75(3): 481–9.
    • (2016) Ann Rheum Dis , vol.75 , Issue.3 , pp. 481-489
    • Ravelli, A.1    Minoia, F.2    Davì, S.3
  • 17
    • 84895083284 scopus 로고    scopus 로고
    • Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China
    • Li F, Li P, Zhang R, et al. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China. Med Oncol 2014; 31(4): 902.
    • (2014) Med Oncol , vol.31 , Issue.4 , pp. 902
    • Li, F.1    Li, P.2    Zhang, R.3
  • 18
    • 79953220496 scopus 로고    scopus 로고
    • Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center
    • Machaczka M, Vaktnäs J, Klimkowska M, Hägglund H. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma 2011; 52(4): 613–619.
    • (2011) Leuk Lymphoma , vol.52 , Issue.4 , pp. 613-619
    • Machaczka, M.1    Vaktnäs, J.2    Klimkowska, M.3    Hägglund, H.4
  • 19
    • 84885636323 scopus 로고    scopus 로고
    • Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution
    • Yu JT, Wang CY, Yang Y, et al. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Ann Hematol 2013; 92(11): 1529–1536.
    • (2013) Ann Hematol , vol.92 , Issue.11 , pp. 1529-1536
    • Yu, J.T.1    Wang, C.Y.2    Yang, Y.3
  • 20
    • 46849090930 scopus 로고    scopus 로고
    • Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis
    • Shin HJ, Chung JS, Lee JJ, et al. Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. J Korean Med Sci 2008 Jun; 23(3): 439–444.
    • (2008) J Korean Med Sci , vol.23 , Issue.3 , pp. 439-444
    • Shin, H.J.1    Chung, J.S.2    Lee, J.J.3
  • 21
    • 84861685616 scopus 로고    scopus 로고
    • Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment
    • Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012 Jun; 13(4): 289–98.
    • (2012) Genes Immun , vol.13 , Issue.4 , pp. 289-298
    • Ravelli, A.1    Grom, A.A.2    Behrens, E.M.3    Cron, R.Q.4
  • 22
    • 84929512334 scopus 로고    scopus 로고
    • Clinical study of DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis
    • Wang Y, Huang W, Wei N, et al. Clinical study of DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Zhonghua Xue Ye Xue Za Zhi 2014; 35(10): 901–904.
    • (2014) Zhonghua Xue Ye Xue Za Zhi , vol.35 , Issue.10 , pp. 901-904
    • Wang, Y.1    Huang, W.2    Wei, N.3
  • 23
    • 84989297101 scopus 로고    scopus 로고
    • Alternative therapy for epstein-barr virus related hemophagocytic lymphohistiocytosis
    • Al Asad O, Salam A, Mannem S, Ninan M, Markowitz A, Jana B. Alternative therapy for epstein-barr virus related hemophagocytic lymphohistiocytosis. Case Rep Oncol Med 2015; 2015: 508387.
    • (2015) Case Rep Oncol Med , vol.2015 , pp. 508387
    • Al Asad, O.1    Salam, A.2    Mannem, S.3    Ninan, M.4    Markowitz, A.5    Jana, B.6
  • 24
    • 84880319443 scopus 로고    scopus 로고
    • Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens
    • Chellapandian D, Das R, Zelley K, et al. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol 2013; 162(3): 376–382.
    • (2013) Br J Haematol , vol.162 , Issue.3 , pp. 376-382
    • Chellapandian, D.1    Das, R.2    Zelley, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.